SpyGlass Pharma (SGP) Stock Price, News & Analysis
Company Description
SpyGlass Pharma (NASDAQ: SGP) is classified in the biotechnology industry within the Surgical & Medical Instruments & Apparatus sector and carries a market capitalization of $876.3M, ranking #3,152 among all listed U.S. companies by market cap.
For FY2025, SpyGlass Pharma reported net income of -$39.9M and diluted earnings per share of -$17.98.
This page collects what Stock Titan holds for SGP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SpyGlass Pharma (SGP) stock last closed at $26.20. At a market capitalization of $876.3M, SGP is classified as a small-cap stock with approximately 33.4M shares outstanding.
SGP Rankings
Latest News
SpyGlass Pharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, conferences, clinical trial, IPO, offering. View all SGP news →
SEC Filings
SpyGlass Pharma has filed 5 recent SEC filings, including 2 Form 10-Q, 2 Form 8-K, 1 Form 10-K. The most recent filing was submitted on August 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGP SEC filings →
Financial Highlights
operating income reached -$41.4M, and net income was -$39.9M. Diluted earnings per share stood at -$17.98. The company generated -$32.7M in operating cash flow. With a current ratio of 12.67, the balance sheet reflects a strong liquidity position.
Upcoming Events
Phase 3 enrollment completion
SpyGlass Pharma has 1 upcoming scheduled event. The next event, "Phase 3 enrollment completion", is scheduled for January 1, 2027 (in 136 days). Investors can track these dates to stay informed about potential catalysts that may affect the SGP stock price.
Short Interest History
Short interest in SpyGlass Pharma (SGP) currently stands at 1.1 million shares, down 13.7% from the previous reporting period, representing 3.5% of the float. Since February 2026, short interest has increased by 524.5%. This relatively low short interest suggests limited bearish sentiment. The 7.9 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for SpyGlass Pharma (SGP) currently stands at 7.9 days, up 44.4% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 628.4% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.1 to 19.4 days.
SGP Company Profile & Sector Positioning
SpyGlass Pharma (SGP) operates in the Biotechnology industry within the broader Surgical & Medical Instruments & Apparatus sector and is listed on the NASDAQ. In monthly performance, the stock ranks #476 among all tracked companies.